Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (31-40 of 315) with videos related to

Pageof 32
Sort By:
Cancer Discovery|May 2, 2022
Colorectal Cancer Genomics by Genetic AncestryCathy Eng, Andreana N Holowatyj
International Journal of Surgical Oncology|June 8, 2012
The current state of targeted agents in rectal cancerDae Dong Kim, Cathy Eng
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
The treatment of colorectal carcinoma: standard chemotherapy and beyondCathy Eng, James L Abbruzzese
Nature Reviews. Gastroenterology & Hepatology|November 28, 2024
Moving towards more personalized approaches in locally advanced and metastatic colorectal cancerChelsie K Sievers, Cathy Eng
Journal of the Advanced Practitioner in Oncology|July 18, 2014
Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapyNinoska N Silva, Cathy Eng
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Immunotherapy in Localized Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors: Are We Ready for a New Standard of Care?Kristen K Ciombor, Cathy Eng
Lancet (London, England)|June 8, 2024
The developing role of theranostics in NETsRobert A Ramirez, Cathy Eng
Journal of Gastrointestinal Cancer|June 9, 2014
Cetuximab in refractory squamous cell carcinoma of the anal canalJane E Rogers, Cathy Eng
Expert Opinion on Investigational Drugs|September 18, 2012
The promise of mTOR inhibitors in the treatment of colorectal cancerDae-Dong Kim, Cathy Eng
Expert Opinion on Pharmacotherapy|August 29, 2019
Pharmacotherapeutic considerations for elderly patients with colorectal cancerJane E Rogers, Cathy Eng
Pageof 32

Showing results (31-40 of 315) with videos related to

Sort By:
Pageof 32
Cancer Discovery|May 2, 2022
Colorectal Cancer Genomics by Genetic AncestryCathy Eng, Andreana N Holowatyj
International Journal of Surgical Oncology|June 8, 2012
The current state of targeted agents in rectal cancerDae Dong Kim, Cathy Eng
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
The treatment of colorectal carcinoma: standard chemotherapy and beyondCathy Eng, James L Abbruzzese
Nature Reviews. Gastroenterology & Hepatology|November 28, 2024
Moving towards more personalized approaches in locally advanced and metastatic colorectal cancerChelsie K Sievers, Cathy Eng
Journal of the Advanced Practitioner in Oncology|July 18, 2014
Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapyNinoska N Silva, Cathy Eng
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Immunotherapy in Localized Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors: Are We Ready for a New Standard of Care?Kristen K Ciombor, Cathy Eng
Lancet (London, England)|June 8, 2024
The developing role of theranostics in NETsRobert A Ramirez, Cathy Eng
Journal of Gastrointestinal Cancer|June 9, 2014
Cetuximab in refractory squamous cell carcinoma of the anal canalJane E Rogers, Cathy Eng
Expert Opinion on Investigational Drugs|September 18, 2012
The promise of mTOR inhibitors in the treatment of colorectal cancerDae-Dong Kim, Cathy Eng
Expert Opinion on Pharmacotherapy|August 29, 2019
Pharmacotherapeutic considerations for elderly patients with colorectal cancerJane E Rogers, Cathy Eng
Pageof 32